key: cord-0931982-jrf7tm5u
authors: Claise, Catherine; Saleh, Jumana; Rezek, Marwa; Vaulont, Sophie; Peyssonnaux, Carole; Edeas, Marvin
title: Low Transferrin Levels Predict Heightened Inflammation in COVID-19 Patients: New Insights
date: 2021-12-21
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.12.340
sha: 65a0a0ea21683c5cf0cc3092ed50af576e1685c0
doc_id: 931982
cord_uid: jrf7tm5u

Objectives : Mounting evidence links hyper-inflammation in gravely ill patients to low serum iron levels and hyper-ferritinemia. However, little attention was given to other iron-associated markers such as transferrin. The aim of this study is to investigate the association of different iron parameters in severe COVID-19 disease and their relation to disease severity. Subjects and methods : This study involved 73 hospitalized patients positive for SARS-CoV-2. Patients were classified into two groups according to symptom severity as mild and severe. Blood levels of anti-SARS-CoV2 antibodies, IL-6, CRP and iron-related biomarkers were measured. Results : The results revealed a significant increase in IL-6, CRP and ferritin levels and decreased transferrin and iron levels in severe COVID-19 disease. Transferrin negatively predicted variations in IgM and IgG levels (P< 0.001), as well as 34.4% and 36.6% increase in IL-6 and CRP levels respectively (P< 0.005). Importantly, transferrin was the main negative predictor of ferritin levels, determining 22.7% of serum variations (P< 0.001). Conclusion : Reduced serum transferrin and iron levels, along with the increased CRP and high ferritin, were strongly associated with the heightened inflammatory and immune state in COVID-19 disease. Transferrin can be used as valuable predictors of increased severity and progression of disease.

The Coronavirus disease (COVID-19) is a severe acute respiratory disease caused by the emerging virus SARS-CoV-2. This notorious contagion first appeared in Wuhan-China in 2019, and has spread to become a pandemic that crippled the world and inflicted serious threats to the global public health safety. The high contagiousness and swift spreading of this virus, along with the global increase in the mortality rate has raised the alarm of the medical community that has been exerting tremendous efforts through medical interventions and mass vaccination in an attempt to control it and possibly eradicate it. (Hu et al., 2021) .

The severity of this disease varies considering individual and regional factors. Commonly, the infection may be asymptomatic or associated with mild symptoms manifested by a fever, dry cough, myalgia and fatigue.

However, in severe cases, the patient suffers from acute respiratory distress that may develop into septic shock and potential death. (He et al., 2021) . The severe cases are associated with a hyper-inflammatory state, namely the cytokine storm, which is induced by the high viral load within the body . This involves overexpression of pro-inflammatory cytokines, notably the IL-6, IL-10, TNF-α, that could aggravate the acute respiratory distress syndrome and lead to widespread tissue damage resulting in multi-organ failure and death (Copaescu et al., 2020) . It was suggested that tocilizumab, a recombinant human anti-IL-6 receptor antibody, may play a vital role in reducing the mortality rates in patients with severe COVID-19 complications (Copaescu et al., 2020 ).

An increasing body of evidence recently showed that the COVID-19 hyper-inflammatory state exhibits other important hallmarks such as hyper-ferritinemia and altered iron homeostasis (Carubbi et al., 2021; Sonnweber et al., 2020) . Indeed, hyper-ferritinemia and low serum iron levels are among key components that significantly correlate with high mortality in COVID-19 patients (Banchini et al., 2021; Mehta et al., 2020) . Consequently, measuring iron and ferritin levels in COVID-19 patients was suggested to predict disease severity and fatal complications.

We were among the first to address the possible impact of hyper-ferritinemia, and altered iron homeostasis on COVID-19 pathogenesis . We proposed that hyper-ferritinemia is associated with a state of iron toxicity, and hyper-ferritinemia, along with decreased serum transferrin levels, could reflect a state of intracellular iron overload. Therefore, we suggested, that targeting altered iron metabolism may be of therapeutic value in treating the consequences of severe COVID-19 disease.

Notably, recent studies have shown that the use of iron chelators, such as lactoferrin, could have a positive impact on the reduction of the inflammatory risk in patients (Habib et al., 2021) . However, the relationship between altered iron metabolism and the severity of COVID-19 disease is not yet fully understood.

Studies on COVID-19 patients have reported the significance of altered cytokines levels such as IL-6 (C. Zhang et al., 2020) , C-reactive protein (Skevaki et al., 2020) , iron and ferritin, as well as the transferrin receptors and other factors in discriminating between the mild and severe forms of the COVID-19 infections in humans (Lv et al., 2021) . It was also recently revealed that increased calprotectin levels (an ironsequestering host-defense protein) in the blood (Mahler et al., 2021) , and in the feces (Giuffrè et al., 2020) , can be used as predictors for the severity of COVID-19 in patients. However, little attention has been given to blood transferrin levels and its saturation (TSAT, %) in this regard.

In order to evaluate our initial hypothesis which suggests the possible impact of hyper-ferritinemia, and altered iron homeostasis on COVID-19 pathogenesis , the goals in this study were to investigate the relationship between the cytokine storm components and iron metabolism biomarkers in COVID-19 disease, and to understand alterations in iron homeostasis during severe SARS-CoV-2 infection.

This retrospective study included 73 patients hospitalized in the Hospital Groupe Hospitalier Sud-Ile-de-France (GHSIF). All patients, including 42 males and 31 females were confirmed to be infected by SARS-CoV-2 according to the World Health Organization guidelines (World Health Organization, 2020). All the administered patients were followed up by monitoring their age, the appearance of symptoms, blood tests, and management strategy, until death or discharge from the ICU or the hospital.

Biological samples were collected via Nasopharyngeal swabs. Total RNA extraction and Real-time PCR quantification was carried out by the fully automated ELITe InGenius ELITECH analyser using the SARS-CoV-2 ELITe MGB Kit. Results for genes RdRp, E and N with a CT > 43 were considered negative.

Demographic information, age and sex, medical history and co-morbidities, laboratory results, in-hospital treatments, and clinical outcomes were registered from the Sillage informatic medical system. Laboratory measurements included inflammatory factors (C-reactive protein (CRP), and Interleukin-6 (IL-6), anti-SARS-CoV-2 antibodies (IgM and IgG), and serum iron markers (ferritin, transferrin and iron). The laboratory tests were performed at least once during the follow-up of the patients.

The serum levels of IL-6, ferritin, transferrin and iron were measured by the fully automated analyzers Cobas 8000.c502, and Cobas 8000.e801, using the standard laboratory methods: IL-6 and ferritin by ECLIA (electrochimiluminescence), transferrin by immunoturbidimetry and iron by photometry (ferrozine reactif). All solvents, reagents and kits needed for these tests were purchased from Roche Diagnostics.

Anti-SARS-CoV-2 antibodies (IgM and IgG) were measured by the Orgentec Iflash analyser using the SARS-CoV-2 IgM and IgG antibody detection kits YHLO (chemiluminescence method).

The transferrin saturation (TSAT%) was calculated according to the following formula:

Transferrin saturation (TSAT%) = (serum iron ((µmol) ⁄ L)) / (Total iron Binding capacity ((µmol) ⁄ L)) × 100

Total iron Binding capacity ((µmol) ⁄ L) =Transferrin x 25.

All the statistical analysis was perfumed using IBM SPSS statistics 23 software. The Kolmogorov-Smirnov test was used to test for the normality of the distribution of data variables. The difference between data variables was tested using the Mann-Whitney non-parametric test, and the correlations between parameters were computed by Spearman correlation coefficients. Predictors of inflammatory and immune factors were determined by stepwise multiple regression analysis after log transformation of non-parametric data. A p-value of 0.05 was considered significant in all the results. All measured parameters were included in the regression analysis including iron indices, immune and inflammatory mediators, and age.

Results 73 hospitalized patients who tested positive for SARS-CoV-2, were included in this clinical study. Among the patients, 58% (n = 42) were males, and 42% (n = 31) were females. The overall median age was 63.34 years, and the median ages of the males and females were 60.38 and 67.35 years, respectively ( Table 1) .

The patients were divided into two groups according to the severity of the symptoms having either mild or severe COVID-19 disease. The gender classification in the two categories is summarized in Table 1 .

The results of the mean levels for the different blood parameters in all patients are summarized in Table 2 .

Anti-SARS-CoV-2 IgM and IgG serum levels showed higher trends in the severe group compared to the mild group; however, the results were not statistically significant. There was a significant difference between the mild and severe groups of patients considering the common acute phase reactants of inflammation including CRP, IL-6, and ferritin. Similar results were obtained considering these factors when analyzing males and females separately. Furthermore, the results showed markedly decreased serum transferrin levels in the COVID-19 severe group compared to the mild group. There was a decreased trend in iron levels in the severe group compared to the mild group that did not reach significance (P=0.06).

Spearman analysis, presented in Table 3 , shows strong significant correlations between the different acute phase reactants measured in this study. As for iron-related indices, ferritinemia increased positively with increased IL-6 and CRP serum levels. Conversely, Transferrin levels had a strong negative correlation with IL-6, CRP, and ferritin. Iron levels, similar to transferrin, had a strong negative correlation with IL-6 and CRP.

Stepwise regression analysis including measured iron indices, inflammatory mediators and age showed that the immune factors anti-SARS-CoV-2 (IgM and IgG) were mainly predicted by transferrin serum levels.

Results showed that anti-SARS-CoV-2 (IgM and IgG) were mainly predicted by decreased transferrin serum levels. Transferrin levels negatively predicted about 19% variation in IgM levels (P< 0.001), and 15.6% of the variation in IgG levels (P< 0.001) in the population study. As for inflammatory factors, results showed that serum iron followed by transferrin levels negatively predicted a 34.4% increase in IL-6 levels (p< 0.005), and 36.6% increase in CRP levels (P< 0.001). These findings were accentuated in severe COVID-19 disease showing that iron and transferrin negatively predicted a 40% increase in IL-6 (p< 0.02), and 48.9% increase in CRP levels (P< 0.01). Further, transferrin was the main negative predictor of ferritin levels, and determined 22.7% variation in ferritin levels (P< 0.001). Altogether, these findings suggest a strong negative correlation between iron and transferrin levels and the amplified state of inflammation during severe complications of COVID-19 disease.

The findings of this study shed light on the association between iron metabolism indicators and the severity of COVID-19 by investigating their association with COVID-19 related changes in major inflammatory markers. This paves way for addressing potential mechanisms underlaying severity and progression of the disease and to, suggest potential therapeutic targets. The study reflected that hypoferremia, a main predictor of inflammation, cannot be considered as a major predictor of disease severity. Our results agree with other studies that revealed that serum iron levels showed no significant change between mild and severe COVID-19 cases Lv et al., 2021) . Moreover, the results showed that serum transferrin and iron levels can be used to independently predict the intensity of the immune response in terms of IgG and IgM anti-SARS-CoV-2 antibody measures as well as the inflammatory mediators of the cytokine storm, IL-6 and CRP as indicated by alterations in iron metabolism that were significantly linked to both the innate and the humoral immunity in COVID-19 disease.

Based on the strong association of altered iron metabolism mainly with IL-6 (the main actor in COVIDassociated cytokine storm), we were able to propose a mechanism for the role of iron metabolism dysbiosis in viral replication and propagation, and suggest a sequence of events as described in Figure 1 . In severe cases of COVID-19, increased levels of IL-6 contribute to increased hepatic synthesis of CRP, and inhibition of transferrin release which partially results from inflammation and hypoxia (Li et al., 2019) (Castell et al., 1989) . IL-6 may also trigger the synthesis of hepcidin and ferritin . Hepcidin, is the key regulatory protein of intracellular iron homeostasis (Ganz & Nemeth, 2012) , and can be also partially released by myeloid cells, notably macrophages, in inflammation and infections (D'Angelo, 2013; Peyssonnaux et al., 2006) . It also plays an important role in inflammation via the iron retention in macrophages and dendritic cells, as well as in the reduction of iron intestinal absorption thus decreasing free plasma iron levels (Collins et al., 2008 ) and iron's availability for red blood cell synthesis (Weiss et al., 2019) thus re-emphasizing that the IL-6 -hepcidin axis is responsible for inflammation related hypoferremia .Additionally, in the context of the COVID-19 pandemic, one recent Italian cohort study showed that the hepcidin levels, similar to hyperferritinemia and hypoferremia, were shown to predict the severity and mortality of COVID-19 (Nai et al., 2021) . Moreover, ferritin appeared to play a more significant role in COVID-19 pathogenesis rather than serving as a simple marker of disease progression as shown in our previous report .

The tissue damage, seen in the severe forms of COVID-19 may lead to excessive ferritin leakage from the cells (Taneri et al., 2020) . Extremely high ferritinemia, detected in patients with severe cases of COVID-19, could trigger mitochondrial dysfunction, leading to iron-mediated oxidative stress, production of reactive oxygen species (ROS), and aggravation of pro-inflammatory cytokine release (Ganji & Reddy, 2021) .

Accordingly, it was shown that techniques such as therapeutic plasma exchange might be beneficial for SARS-CoV-2 infected patients as this will decrease the levels of ferritin and cytokines (Gómez-Pastora et al., 2020) . As reviewed in our previous paper , Excess intracellular iron can trigger mitochondrial damage by ROS accumulation, leading to ferroptosis and, thus, to tissue and organ damage.

A main consequence of iron-dependent ferroptosis in COVID-19 might include cognitive impairment, loss of taste and smell . Moreover, the iron associated-platelet mitochondrial dysfunction in the blood is associated with the hyper-coagulopathy commonly seen in COVID-19 patients .

Transferrin delivers iron into cells by binding to its specific transferrin receptors (Fillebeen et al., 2019) .

Many infectious agents, including SARS-CoV-2 virus, require iron for their replication and propagation (Barber & Elde, 2015) suggesting competition between the host and the virus as proposed in Figure 2 . The result of this competition is case-related and is affected by several factors such as age, gender, comorbidities and others . Thus, a hypoxic-iron rich environment (Dhama et al., 2020) and respiratory distress seen in severe COVID-19 cases are advantageous to the virus (Huang et al., 2021) .

Interestingly, it was noted that geographical areas with higher prevalence of iron deficiency were less affected by COVID-19, SARS, H1N1 and others (Menshawey et al., 2020) . During inflammation, the body restricts iron access from pathogens by accumulating it in body cells either by transferrin-transferrin receptor or via hepcidin (Barber & Elde, 2015) . Thus, one way to deprive iron supply to the virus as suggested in previous studies, is by using iron chelators to decrease the risk of inflammation . We further suggest increasing the expression of intracellular iron-associated proteins such as ferroportin to treat severe COVID-19 patients. Previous studies showed successful anti-viral effects on other RNA viruses such as the HIV, by increasing intracellular iron efflux via increasing ferroportin expression (Kumari et al., 2016) .

Also, the transferrin receptor was also found to mediate the entry of several viruses into the host cells (Wessling-Resnick, 2018) . This includes SARS-CoV-2 which can interact specifically with this receptor using its spike protein during the viral entry stage (S. Zhang et al., 2018) . Consequently, the use of anti-TfR antibodies can have potent anti-viral effects (Tang et al., 2020) . Additionally, a recent study has shown that the novel SARS-CoV-2 virus has a hepcidin-like activity due to similarities between the protein and the viral spikes (Cavezzi et al., 2020) . Emerging evidence is suggesting that SARS-CoV-2 virus might be able to manipulate the parameters of the iron metabolism by bypassing the IL-6 pathway through mitochondrial activity of immune cells .

Our study has its limitations. Since our work consists of a retrospective study, the correlation between the biomarkers of iron metabolism and COVID-19 severity cannot be concluded in a final potential bias; The study group is relatively small, and a larger study with a greater sample size is needed to assess all the iron metabolism biomarkers. Moreover, anti-S antibody levels were not investigated, and data regarding the time of collection and some parameters such as BMI or co-morbidities were not available to be included in the analysis. Measurement of the hepcidin levels should be performed as well as the levels of the soluble transferrin receptors. Moreover, the correlation of soluble transferrin receptors with other parameters, such as IL-6, CRP, and iron metabolism biomarkers should be also assessed. Finally, we couldn't assess the transferrin blood levels nor the TSAT correlation with the septic shock nor the death due to the low incidence of these to outcomes in our patients.

The limited understanding of the viral intrusion and its effect on systemic iron metabolism requires further investigation. Despite efforts in studying the association between iron metabolism biomarkers in COVID-19 disease, the role of altered iron metabolism dysfunction in COVID-19 pathogenesis and increased severity is not fully understood. Our research will continue to investigate many unanswered questions. Does the hepcidin mimicry to viral spike proteins result in IL-6-independent hyper-ferritinemia, inducing ferroptosis? 

This study adds to the understanding of the association between iron metabolism and inflammatory markers in COVID-19. It suggested that transferrin may be a central factor in COVID-19 pathogenesis as reflected by the strong predictive association of low transferrin with increased immune and inflammatory factors particularly IL-6, and ferritin in severe COVID-19 disease, not seen in the mild cases. This hints that transferrin may play central role in COVID-19 pathogenesis such as enhancing hepcidin synthesis by the liver, and contributing to ferritin release. Combining hyper-ferritinemia with decreased transferrin levels in severely ill patients may suggest a state of an intracellular iron overload, and release of the iron ferric form in the extracellular milieu. These findings reflect that, the low transferrin levels, along with the increased CRP and high ferritin, can be used as valuable predictors of increased severity and progression of COVID-19 disease. Modulating cellular iron metabolism can present as a serious medical emergency in the management of the severe COVID-19 cases.

The authors declare no conflict of interest.

All authors have approved the final version of the manuscript. Concept: ME, JS and CC. Development of idea and design: All authors. Access, acquisition, and analysis of data: All authors. Statistical analysis and tables: CC, JS, ME. Interpretation of data: All authors. The authors attest that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

This retrospective study was conducted in compliance with the ethical guidelines of the 1975 Declaration of Helsinki and was approved on July 23, 2020 by Hospital Groupe Hospitalier Sud-Ile-de-France (GHSIF).

Participants' confidentiality was strictly observed throughout the study by using an anonymous unique serial number for each subject and restricting data only to the investigators.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors. Iron within the human body is needed to maintain homeostasis. It is primarily involved in the red blood cells synthesis within the bone marrow. It is also essential for myoglobin and energy production in muscles and for other roles in metabolism, health growth, and differentiation of immune cells. However, many viruses rely on iron to efficiently replicate and propagate within the host. Viruses try to highjack the host iron metabolism during infections. The answer on the question whether the virus or the host will win the competition will remain personalized and caserelated. Different factors could affect the results of such a war such as age, sex, prior co-morbidities, altered gut microbiota, and others. 

Serum ferritin levels in inflammation: a retrospective comparative analysis between COVID-19 and emergency surgical non-COVID-19 patients

Buried Treasure: Evolutionary Perspectives on Microbial Iron Piracy

Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection

Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing

Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units

Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review

Hepcidin regulation of iron transport

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection

Role of hepcidin in the pathophysiology and diagnosis of anemia

Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease

Coronavirus Disease 2019-COVID-19

Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?

Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load

Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases

Hepcidin and iron homeostasis

COVID-19-Induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: Hypothesis regarding mechanism of intestinal damage associated with COVID-19

Hyperferritinemia in critically ill COVID-19 patients -Is ferritin the product of inflammation or a pathogenic mediator

The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators

Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis

Characteristics of SARS-CoV-2 and COVID-19

Hypoxia and viral infectious diseases

Increased iron export by ferroportin induces restriction of HIV-1 infection in sickle cell disease

Hypobaric hypoxia regulates iron metabolism in rats

Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival

Association between iron status and the risk of adverse outcomes in COVID-19

Circulating Calprotectin as a Biomarker of COVID-19 Severity

COVID-19: consider cytokine storm syndromes and immunosuppression

Low iron mitigates viral survival: insights from evolution, genetics, and pandemics-a review of current hypothesis

Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens

The COVID-19 Cytokine Storm; What We Know So Far

Mitochondria and microbiota dysfunction in COVID-19 pathogenesis

Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis

Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus

Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study

Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis

Transferrin receptor is another receptor for SARS-CoV-2 entry

Mitochondrial Functions in Infection and Immunity

Anemia of inflammation

Crossing the iron gate: Why and how transferrin receptors mediate viral entry

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Transferrin receptor 1 is a supplementary receptor that assists transmissible gastroenteritis virus entry into porcine intestinal epithelium 11 Medical and Health Sciences 1108

IL-6, among other cytokines, is the main actor on the liver to release CR, hepcidin and to reduce the synthesis of Transferrin. Hepcidin, the key regulatory protein of intracellular iron homeostasis, is also released by macrophages upon the action of IL-6 in inflammation and infections

We acknowledge all participating hospitals and affiliated researchers for their contribution and support. We thank Prisca Gebrayel for her technical support.